Tag: shareholders

WEST PALM BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- LXP Industrial Trust (“LXP”) (NYSE: LXP), a real estate investment trust (REIT) focused on Class A warehouse and distribution investments, today announced that it declared a regular common share dividend for the quarter ending June 30, 2025 of $0.135 per common share payable on or about July 15, 2025 to common shareholders of record as of June 30, 2025.

MONTREAL, June 16, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, declared a quarterly dividend of US $0.45 per outstanding common share of its capital payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025.

LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces that its 2025 Annual General Meeting of Shareholders (the “Annual Meeting”) was held at 9 a.m. local time on June 16, 2025 at the offices of Baker Botts LLP, 30 Rockefeller Plaza, New York, New York, 10112, U.S.A..

CALGARY, Alberta, June 16, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on July 15, 2025 to shareholders of record on June 30, 2025.

BOCA RATON, FL, June 16, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it will publish its June 2025 Shareholder Letter and Business Update on its website at https://defidevcorp.com/investor on Wednesday, June 25, 2025, at approximately 4:00 p.m. Eastern Time.

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to respond to a misleading press release published earlier today by Apollo Technology Capital Corporation (“Apollo”) prematurely claiming that it considers the results of the annual and special meeting of shareholders scheduled to take place at 3:00 p.m. today (the “Meeting”) to be a clear victory for Apollo.

Disclosure of trading in own shares
from 06/09/2025 to 06/13/2025